Caption Management’s Gilead Sciences GILD Stock Holding History

Caption Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$27.9M	Buy	200,000 +100,000	+100%	+$14M	0.16%	129
2025 Q4	$12.3M	Buy	100,000 +70,000	+233%	+$8.51M	0.08%	283
2025 Q3	$3.33M	Sell	30,000 -340,000	-92%	-$38.6M	0.03%	636
2025 Q2	$41M	Buy	+370,000	New	+$39.4M	0.45%	29
2024 Q1	–	Sell	-18,400	Closed	-$1.49M	–	1372
2023 Q4	$1.49M	Buy	+18,400	New	+$1.43M	0.02%	698
2022 Q4	–	Sell	-113,900	Closed	-$7.03M	–	1423
2022 Q3	$7.03M	Sell	113,900 -39,600	-26%	-$2.5M	0.1%	254
2022 Q2	$9.49M	Buy	153,500 +130,000	+553%	+$8.05M	0.13%	202
2022 Q1	$1.4M	Hold	23,500	–	–	0.02%	859
2021 Q4	$1.71M	Sell	23,500 -65,000	-73%	-$4.48M	0.02%	844
2021 Q3	$6.18M	Buy	88,500 +35,000	+65%	+$2.46M	0.07%	368
2021 Q2	$3.68M	Buy	+53,500	New	+$3.57M	0.05%	467
2019 Q4	–	Sell	-50,000	Closed	-$3.17M	–	905
2019 Q3	$3.17M	Buy	+50,000	New	+$3.27M	0.16%	169

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Caption Management's GILD Position: Q4 2025 in Review

Caption Management sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 49,900 shares — an estimated $6.06M sold.

Caption Management first reported a position in GILD in Q3 2019 and held it in 9 quarters. The position peaked at $16.5M in Q2 2025. 2,215 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

Caption Management reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
Caption Management sold 49,900 Gilead Sciences shares in Q4 2025, an estimated $6.06M.
Caption Management first reported a position in Gilead Sciences in Q3 2019 and held it in 9 quarters.
Caption Management's Gilead Sciences position peaked at $16.5M in Q2 2025.
2,215 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on Caption Management's 13F filing for Q4 2025, filed 17 Feb 2026.